Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-17-004755)

Filing Details

Accession Number:: 0000899243-17-004755
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-02-21 16:33:12
Reporting Period:: 2017-02-17

Filing Date:: 2017-02-21
Accepted Time:: 2017-02-21 16:33:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1341235	Aldeyra Therapeutics Inc.	ALDX	Biological Products, (No Disgnostic Substances) (2836)	MA

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1021015	Richard Douglas	C/O Aldeyra Therapeutics, Inc. 131 Hartwell Avenue, Suite 320 Lexington MA 02421		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-02-17	40,000	$4.50	40,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents shares of common stock purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 17, 2017.